For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds - statnews.com
For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds statnews.com J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study Reuters ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win Fierce Pharma PROTEUS: Apalutamide plus ADT before and after RP cuts metastasis risk Urology Times ASCO26: Big win for Erleada in perioperative prostate cancer pharmaphorum
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.